Cara Therapeutics Inc

Company Snapshot
107 Elm Street
Stamford, CT 06902
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 106
https://www.caratherapeutics.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$34,601,000
Operating Income
$5,385,000
($89,083,000)
($87,535,000)
Net Income
$8,410,000
($88,441,000)
($85,474,000)
2020
Gross Profit
Operating Income
$5,385,000
Net Income
$8,410,000
2021
Gross Profit
Operating Income
($89,083,000)
Net Income
($88,441,000)
2022
Gross Profit
$34,601,000
Operating Income
($87,535,000)
Net Income
($85,474,000)
The above data on Cara Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Christopher Posner
President, Chief Executive Officer and Director
$1,194,000
$1,306,220
$9,759
$2,509,979
Christopher Posner
$2,509,979
President, Chief Executive Officer and Director
Ryan Maynard
Chief Financial Officer and Principal Accounting Officer
$187,700
$1,701,405
$197
$1,889,302
Ryan Maynard
$1,889,302
Chief Financial Officer and Principal Accounting Officer
Joana Goncalves
Chief Medical Officer
$737,540
$803,104
$9,711
$1,550,355
Joana Goncalves
$1,550,355
Chief Medical Officer
Martin Vogelbaum
Chairman of the Board
$115,000
$499,870
$0
$614,870
Martin Vogelbaum
$614,870
Chairman of the Board
Harrison Bains
Independent Director
$65,000
$199,934
$0
$264,934
Harrison Bains
$264,934
Independent Director
Cara Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us